🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the pharmacokinetics, safety, toler...
Status
Completed
Location
Samsung Investigational Site
Start Date
2014-02
Trial ID
NCT02075073
Treatments Being Tested
The purpose of the study is to demonstrate demonstrate the pharmacokinetic ...
Status
Completed
Location
Q Pharm
Start Date
2019-04-01
Trial ID
NCT03776240
Treatments Being Tested
To compare the efficacy and safety of PERT-IJS (Proposed biosimilar Pertuzu...
Status
Terminated
Location
Chopda Medicare & Research Centre Pvt. Ltd,
Start Date
2025-01-06
Trial ID
NCT06038539
The purpose of this study is to compare ALT02 (Trastuzumab biosimilar) and ...
Status
Completed
Location
Multiple Locations
Start Date
2016-02-09
Trial ID
NCT03242239
Treatments Being Tested
This phase II trial studies the immunologic response and side effects of us...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-04-20
Trial ID
NCT04329065
This study is to prove that there is no difference in the number of healthy...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2014-01
Trial ID
NCT02015156
Treatments Being Tested
Non-randomized, open label, multicentric translational research study in wo...
Status
Completed
Location
Hospital de Torrevieja
Start Date
2013-10
Trial ID
NCT01973660
Treatments Being Tested
This is a double-blind, two-arm, parallel-group, single-dose study....
Status
Completed
Location
PPD Phase I Clinic
Start Date
2015-12
Trial ID
NCT02665637
Treatments Being Tested
In this study, healthy male volunteers will receive a single intravenous ad...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-05
Trial ID
NCT01603264
Treatments Being Tested
The primary objective of this study was to demonstrate pharmacokinetic simi...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT02594761
Treatments Being Tested